20240702_SCPI_Ringkasan Risalah//Risalah RUPS_31678524_lamp2.pdf

  seluruh saham yang telah dikeluarkan dan disetor penuh oleh Perseroan yaitu sebesar
  3.600.000 (tiga juta enam ratus ribu) saham.

E. KESEMPATAN MENGAJUKAN PERTANYAAN DAN/ATAU PENDAPAT

  Para Pemegang Saham telah diberikan kesempatan untuk mengajukan pertanyaan dan/atau
  pendapat dalam setiap mata acara RUPST dan tidak ada pemegang saham yang mengajukan
  pertanyaan dan/atau pendapat terkait dengan mata acara RUPST.

F. MEKANISME PENGAMBILAN KEPUTUSAN

  Semua keputusan RUPST diambil berdasarkan berdasarkan prinsip musyawarah untuk
  mufakat. Dalam hal musyawarah untuk mufakat tidak tercapai, keputusan akan diambil
  berdasarkan suara terbanyak melalui perhitungan suara pemegang saham yang telah
  disampaikan melalui Electronic General Meeting System KSEI atau eASY.KSEI dan suara
  yang diberikan melalui pemberian kuasa kepada penerima kuasa independen yang ditunjuk
  oleh Biro Administrasi Efek Perseroan yaitu PT FICOMINDO BUANA REGISTRAR, dan
  dengan perhitungan suara dari pemegang saham yang hadir dalam Rapat dilaksanakan dengan
  cara sebagai berikut:
  a. Pemegang saham/kuasanya, yang akan memberikan suara blanko/abstain di mohon untuk
      mengangkat tangan.
  b. Pemegang saham/kuasanya, yang akan memberikan suara tidak setuju di mohon untuk
      mengangkat tangan.
  Untuk Keputusan seluruh agenda Rapat adalah sah jika disetujui oleh lebih dari 1/2 (satu per
  dua) bagian dari seluruh saham dengan hak suara yang sah yang dikeluarkan oleh para
  pemegang saham dan/atau kuasanya yang sah yang hadir dalam Rapat.

G. HASIL PENGAMBILAN KEPUTUSAN

  Hasil pengambilan keputusan dalam RUPST adalah sebagai berikut :


    Mata Acara                                                               Pertanyaan /
                          Setuju         Tidak Setuju         Abstain
      Rapat                                                                   Pendapat

       Pertama          3.556.336            Nihil             Nihil              Nihil
                         (100%)
        Kedua           3.556.336            Nihil             Nihil              Nihil
                         (100%)
       Ketiga           3.556.336            Nihil             Nihil              Nihil
                         (100%)
      Keempat           3.556.336            Nihil             Nihil              Nihil
                         (100%)
       Kelima           3.556.336            Nihil             Nihil              Nihil
                         (100%)

H. HASIL KEPUTUSAN RUPST

  1. Agenda Pertama Rapat, yaitu :
     Menerima dengan baik dan menyetujui Laporan Tahunan Direksi Perseroan mengenai
     Kegiatan Usaha Perseroan dan Tata Administrasi Keuangan Perseroan untuk tahun buku
     yang berakhir pada tanggal 31 Desember 2023, termasuk laporan tugas pengawasan Dewan
     Komisaris Perseroan, serta mengesahkan Laporan Keuangan Perseroan untuk tahun buku
     yang berakhir pada tanggal 31 Desember 2023 yang telah diaudit oleh Kantor Akuntan
     Publik Tanudiredja, Wibisana, Rintis & Rekan, dengan pendapat ”Wajar Tanpa
     Pengecualian”, serta dengan demikian membebaskan anggota Direksi dan Dewan
     Komisaris Perseroan dari tanggung jawab dan segala tanggungan (acquit et de charge) atas
     tindakan pengurusan dan pengawasan yang telah mereka jalankan selama tahun buku 2023,
     sepanjang tindakan-tindakan mereka tercantum dalam Laporan Keuangan Perseroan untuk
     tahun buku yang berakhir pada tanggal 31 Desember 2023.

  2. Agenda Kedua Rapat, yaitu :
     Menyetujui penetapan penggunaan laba bersih Perseroan yang berakhir pada tanggal 31
     Desember 2023 sebesar Rp.186.310.204.000,- (seratus delapan puluh enam miliar tiga
     ratus sepuluh juta dua ratus empat ribu Rupiah) sebagai berikut :
     a. Sejumlah Rp.151.200.000.000,- (seratus lima puluh satu miliar dua ratus juta Rupiah)
         dari laba bersih Perseroan sebagai dividen final yang pembagiannya telah dilakukan
         pada tanggal 31 Desember 2023 melalui mekanisme pembagian dividen interim;
     b. Sejumlah Rp.720.000.000,- (tujuh ratus dua puluh juta Rupiah) dari laba bersih
         Perseroan untuk disisihkan sebagai dana cadangan sebagaimana dimaksud dalam Pasal
         70 Undang-Undang No. 40 Tahun 2007 tentang Perseroan Terbatas ("UUPT");
     c. Sisanya sejumlah Rp.34.390.204.000,- (tiga puluh empat juta tiga ratus sembilan puluh
         ribu dua ratus empat ribu Rupiah) dibukukan sebagai laba ditahan.

  3. Agenda Ketiga Rapat, yaitu :
     1. Menyetujui pelimpahankewenangan kepada Dewan Komisaris Perseroan untuk
        menunjuk Akuntan Publik dan/atau Kantor Akuntan Publik di Indonesia yang terdaftar
        di Otoritas Jasa Keuangan untuk memeriksa/mengaudit Laporan Keuangan Perseroan
        untuk tahun buku yang akan berakhir pada tanggal 31 Desember 2024, sepanjang
        memenuhi kriteria yang telah ditetapkan dalam Rapat ini, dengan tetap memperhatikan
        rekomendasi Komite Audit.
     2. Memberi kewenangan dan kuasa kepada Dewan Komisaris Perseroan untuk
        menetapkan besaran honorarium dan persyaratan lainnya sehubungan dengan
        penunjukan Akuntan Publik dan/atau Kantor Akuntan Publik tersebut dengan tetap
        memperhatikan rekomendasi Komite Audit.
     3. Menyetujui pemberian kewenangan dan kuasa kepada Dewan Komisaris Perseroan
        untuk menetapkan Akuntan Publik dan/atau Kantor Akuntan Publik pengganti dalam
        hal Akuntan Publik dan/atau Kantor Akuntan Publik sebelumnya karena sebab apapun
        tidak dapat menyelesaikan jasa audit Laporan Keuangan Perseroan tahun buku 2024,
        termasuk menetapkan honorarium dan persyaratan penunjukan lainnya yang wajar bagi
        Akuntan Publik dan/atau Kantor Akuntan Publik Pengganti tersebut.

4. Agenda Keempat Rapat, yaitu :
   1. Menyetujui pelimpahan wewenang sepenuhnya kepada Presiden Komisaris untuk
      penetapan besaran gaji dan tunjangan serta fasilitas lainnya bagi anggota Dewan
      Komisaris Perseroan untuk tahun buku yang berakhir pada tanggal 31 Desember 2024;
   2. Menyetujui pelimpahan wewenang sepenuhnya kepada Dewan Komisaris Perseroan
      untuk menetapkan besaran gaji dan tunjangan serta fasilitas lainnya bagi anggota
      Direksi Perseroan untuk tahun buku yang berakhir pada tanggal 31 Desember 2024;
   dengan memperhatikan rekomendasi fungsi Nominasi dan Remunerasi Perseroan.

5. Agenda Kelima Rapat, yaitu :
   1. Menyetujui untuk menerima pengunduran diri Tuan IRSAN BUDIANTO DARMADJI
      dari jabatannya selaku Komisaris Independen Perseroan terhitung sejak ditutupnya
      Rapat iniserta memberikan pembebasan dan pelunasan tanggung jawab sepenuhnya
      (acquit et de charge) atas tindakan pengawasan yang telah dilakukan oleh-nya selama
      masa jabatannya, sepanjang tindakan tersebut tercermin dalam Laporan Tahunan dan
      tercatat pada Laporan Keuangan Perseroan.
   2. Menyetujui untuk mengangkat Tuan GIDEON ADI SIALLAGAN sebagai Komisaris
      Independen Perseroan yang baru terhitung sejak ditutupnya Rapat ini dengan masa
      jabatan meneruskan sisa masa jabatan Tuan IRSAN BUDIANTO DARMADJI sebagai
      Komisaris Independen yang digantikannya.
   3. Sehingga untuk selanjutnya susunan anggota anggota Direksi dan Dewan Komisaris
      Perseroan sejak ditutupnya Rapat ini sampai dengan ditutupnya Rapat Umum
      Pemegang Saham Tahunan Perseroan pada tahun 2026, adalah sebagai berikut:
      --DIREKSI                         :
      -Presiden Direktur                : Tuan DANIEL
      -Direktur                         : Nona YULIANA
      -Direktur                         : Tuan ANDRI SOELASTYO
      --DEWAN KOMISARIS :
      -Presiden Komisaris               : Tuan ANDREAS DAUGAARD JORGENSEN
      -Komisaris                        : Tuan ERWIN AGUNG
      -Komisaris Independen             : Tuan GIDEON ADI SIALLAGAN
   4. Menyetujui memberikan kuasa dan wewenang dengan hak substitusi kepada Direksi
      Perseroan, untuk melakukan segala tindakan yang diperlukan sehubungan dengan
      Keputusan tersebut di atas, untuk menuangkan Keputusan perubahan Pengurus tersebut
      ke dalam akta yang dibuat di hadapan Notaris, serta memberitahukan perubahan
      Pengurus Perseroan tersebut pada instansi yang berwenang, dan melakukan semua
      tindakan yang diperlukan sehubungan dengan Keputusan tersebut sesuai dengan
      peraturan perundang-undangan yang berlaku dan tidak ada tindakan yang dikecualikan

                           Jakarta, 28 Juni 2024
                   PT ORGANON PHARMA INDONESIA Tbk
                                  Direksi

                 ANNOUNCEMENT OF MINUTES MEETING SUMMARY
                  ANNUAL GENERAL MEETING OF SHAREHOLDERS
                      PT ORGANON PHARMA INDONESIA Tbk

The Board of Directors of the Company, domiciled in Central Jakarta, hereby informs that the
Company has held an Annual General Meeting of Shareholders (“AGMS”), namely:

A. DAY/DATE, PLACE, TIME, AND ADDRESS OF THE MEETING

    Day / Date             : Friday, 28 June 2024
    Time                   : 14.07 WIB – 14.56 WIB
    Place                  : Sinarmas MSIG Tower, Lantai 37 Unit 102 & 106 Jalan Jenderal
                      Sudirman Kaveling 21, Setiabudi, Jakarta Selatan

   AGMS Agenda:
   1. Approval of the Annual Reports of the Board of Directors and Board of Commissioners of
      the Company for the Company's business activities and financial administration for the
      fiscal year ending on 31 December 2023, including the endorsement of the Balance Sheet
      and Profit and Loss Statement of the Company for the fiscal year ending on 31 December
      2023, and subsequently granting discharge (acquit et de charge) to the members of the
      Board of Directors and Board of Commissioners of the Company from responsibility for
      the management and supervision of the Company during the respective fiscal year.
   2. Approval of the Utilization of the Company's Net Profit for the fiscal year ending on 31
      December 2023.
   3. Approval for the appointment of the Public Accounting Firm that will audit the Financial
      Statements of the Company for the fiscal year ending 31 December 2024, and
      determination of the honorarium for the Public Accounting Firm.
   4. Approval of the determination of salaries and other allowances for the Directors and
      Board of Commissioners of the Company for the period of January to December 2024.
   5. Approval of the change of the Board of Commissioners of the Company.

  B. MEMBERS OF THE BOARD OF COMMISSIONERS AND THE BOARD OF
     DIRECTORS OF THE COMPANY ATTENDING THE AGMS

     Board of Directors:
     Director               : Mr. ANDRI SOELASTYO

  C. CHAIRMAN OF THE AGMS

     The AGMS was chaired by Mr. ANDRI SOELASTYO as the Director of the Company.

D. ATTENDANCE OF SHAREHOLDERS

  The AGMS was attended by shareholders and/or proxies of shareholders who all represented
  3,556,336 (three million five hundred fifty six thousand three hundred thirty six) shares or
  representing 98.787% (ninety eight point seven eight seven percent) of all shares issued and
  fully paid up by the Company, amounting to 3,600,000 (three million six hundred thousand)
  shares.

E. OPPORTUNITY TO SUBMIT QUESTIONS AND/OR OPINIONS

  Shareholders have been given the opportunity to submit questions and/or opinions in each
  AGMS agenda and there are no shareholders who submit questions and/or opinions related
  to the AGMS agenda.

F. DECISION MAKING MECHANISMS

  All AGMS decisions are taken based on deliberation for consensus. In the event that
  deliberation for consensus is not reached a decision will be taken based on the majority vote
  through the calculation of shareholder votes that have been submitted through the KSEI
  Electronic General Meeting System or eASY.KSEI, and the votes given through the granting
  of power of attorney to the proxy independent appointed by the Company's Securities
  Administration Bureau, which is PT FICOMINDO BUANA REGISTRAR, as well as the
  votes of the shareholders who are physically present at the Meeting, in accordance with the
  provisions:

  a. Shareholders/proxies who wish to vote blank/abstain are asked to raise their hands.
  b. Shareholders/proxies who wish to vote against are asked to raise their hands.

  For decisions, all Meeting agendas are valid if they are approved by more than 1/2 (one half)
  of all shares with valid voting rights issued by the shareholders and/or their legal proxies
  who are present at the Meeting.

G. DECISION MAKING RESULT

  The results of decision making at the AGMS are as follows:

                                                                               Questions/
     Agenda              Agree            Disagree           Abstain           Opinions

      First            3.556.336             Nil                Nil                Nil
                        (100%)
     Second            3.556.336             Nil                Nil                Nil
                        (100%)
      Third            3.556.336             Nil                Nil                Nil
                        (100%)

    Fourth           3.556.336             Nil                Nil                Nil
                      (100%)
    Fifth            3.556.336             Nil                Nil                Nil
                      (100%)

H. RESULT OF AGMS DECISION

  1. The first agenda of the meeting is as follows:
     Accepting and approving the Annual Report of the Board of Directors of the Company
     regarding the Company's Business Activities and Financial Administration for the
     fiscal year ending on 31 December 2023, including the report on the supervisory duties
     of the Board of Commissioners of the Company, and approving the Financial
     Statements of the Company for the fiscal year ending on 31 December 2023, which
     have been audited by the public accounting firm Tanudiredja, Wibisana, Rintis &
     Rekan, with an unqualified opinion, and thereby releasing the members of the Board
     of Directors and Board of Commissioners of the Company from any responsibility and
     liability (acquit et de charge) for their management and supervision actions carried out
     during the fiscal year 2023, as long as their actions are reflected in the Financial
     Statements of the Company for the fiscal year ending on 31 December 2023.

  2. The Second agenda of the meeting is as follows:
     Approving the determination of the utilization of the Company's net profit as of 31
     December 2023 amounting to IDR 186,310,204,000 (one hundred eighty-six billion
     three hundred ten million two hundred four thousand Rupiah) are as follows:
         a. Total of IDR 151,200,000,000 (one hundred fifty-one billion two hundred
             million Rupiah) from the Company's net profit as final dividend, the
             distribution of which was carried out on 31 December 2023 through an interim
             dividend distribution mechanism;
         b. Total of IDR 720,000,000 (seven hundred and twenty million Rupiah) from
             the Company's net profit to be set aside as reserve funds as intended in Article
             70 of Law no. 40 of 2007 concerning Limited Liability Companies ("UUPT");
         c. The remaining amount of IDR 34,390,204,000 (thirty-four million three
             hundred ninety thousand two hundred four thousand Rupiah) was recorded as
             retained earnings.

  3. The Third agenda of the meeting is as follows:
      1) Approved the delegation of authority to the Company's Board of Commissioners
          to appoint a Public Accountant and/or Public Accounting Firm in Indonesia
          registered with the Financial Services Authority to examine/audit the Company's
          Financial Statements for the financial year ending on 31 December 2024, as long
          as they meet the criteria set out in the meeting with taking into account the
          recommendations of the Audit Committee.
      2) Grant authority and power to the Company's Board of Commissioners to
          determine the amount of honorarium and other requirements in connection with
          the appointment of the Public Accountant and/or Public Accounting Firm while
          still taking into account the recommendations of the Audit Committee.

     3) Approve the granting of authority and power to the Company's Board of
        Commissioners to appoint the substitute of Public Accountant and/or Public
        Accounting Firm in the event that the previous Public Accountant and/or Public
        Accounting Firm for any reason is unable to complete the audit services for the
        Company's Financial Report for the 2024 financial year, including determining
        honorarium and other reasonable appointment requirements for the substitute of
        Public Accountant and/or Public Accounting Firm.

4. The Fourth agenda of the meeting, is as follows:
    1) Approve the delegation of full authority to the President Commissioner to
        determine the amount of salary and allowances and other facilities for members
        of the Company's Board of Commissioners for the financial year ending 31
        December 2024;
    2) Approved the delegation of full authority to the Company's Board of
        Commissioners to determine the amount of salaries and allowances and other
        facilities for members of the Company's Board of Directors for the financial year
        ending 31 December 2024;
    taking into account recommendations for the Company's Nomination and
    Remuneration function.

5. The Fifth agenda of the meeting, is as follows:
   1) Agree to accept the resignation of Mr. IRSAN BUDIANTO DARMADJI from his
       position as Independent Commissioner of the Company as of the closing of this
       Meeting and provide full release and discharge of responsibility (acquit et de
       charge) for the supervisory actions carried out by him during his term of office,
       throughout the course of his actions. This is reflected in the Annual Report and
       recorded in the Company's Financial Report.
   2) Approved to appoint Mr. GIDEON ADI SIALLAGAN as the Company's new
       Independent Commissioner as of the closing of this Meeting with a term of office
       continuing the remaining term of office of Mr. IRSAN BUDIANTO DARMADJI
       as Independent Commissioner who he replaced.
   3) Therefore, the composition of the members of the Company's Board of Directors
       and Board of Commissioners from the closing of this Meeting until the closing of
       the Company's Annual General Meeting of Shareholders in 2026, is as follows
     --DIRECTORS                           :
     - President Director                  : Mr DANIEL
     - Director                            : Miss YULIANA
     Director                              : Mr. ANDRI SOELASTYO
     --BOARD OF COMMISSIONERS :
     -President Commissioner               : Mr. ANDREAS DAUGAARD
                                             JORGENSEN
     -Commissioner                         : Mr. ERWIN AGUNG
     -Independent Commissioner             : Mr. GIDEON ADI SIALLAGAN

  4) Agree to grant power and authority with the right of substitution to the Company's
     Directors, to carry out all necessary actions in connection with the aforementioned

Decision, to express the Decision on changes to the Management in a deed made
before a Notary, and to notify the change in the Company's Management to the
agency competent authority, and carry out all necessary actions in connection with
the Decision in accordance with applicable laws and regulations and no actions are
excluded.


                 Jakarta, 28 June 2023
         PT ORGANON PHARMA INDONESIA Tbk
                   Board of Director